Proteins Biomarkers for the Detection of Interstitial Lung Abnormalities in a High-risk Cohort
J.A. Rose(Brigham and Women's Hospital), Gary M. Hunninghake(Hubei University of Science and Technology), Hilary J. Goldberg(Harvard University), Mary B. Rice(Beth Israel Deaconess Medical Center), Iván O. Rosas(Brigham and Women's Hospital), Rachel K. Putman(Brigham and Women's Hospital), A.R. Waich(Baylor College of Medicine), Benjamin A. Raby(Brigham and Women's Hospital), Hiroto Hatabu(Harvard University), G. Axelsson(University of Iceland), Swati Gulati(Pulmonary and Critical Care Associates), Kayla Regan(Boston Children's Hospital), E. Kosak(Brigham and Women's Hospital), A. Synn(University of Maryland, Baltimore)
Cited by 0
Related Papers
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica
|American Journal of Respiratory and Critical Care Medicine|2009|635
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
|New England Journal of Medicine|2011|615
MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
|PLoS Medicine|2008|599